Royce & Associates’s Concentrix CNXC Stock Holding History
Bought
Maintained
Sold
Other funds holding CNXC
Royce & Associates's CNXC Position: Q1 2022 in Review
Royce & Associates sold out of Concentrix (CNXC) in Q1 2022, closing a stake of 10,405 shares — an estimated $1.86M sold.
Royce & Associates first reported a position in CNXC in Q4 2020 and held it in 5 quarters. The position peaked at $9.16M in Q4 2020. 353 funds tracked by Wall St. Rank hold CNXC as of Q1 2022.
- Royce & Associates reported no remaining Concentrix position as of Q1 2022 after selling out during the quarter.
- Royce & Associates sold 10,405 Concentrix shares in Q1 2022, an estimated $1.86M.
- Royce & Associates first reported a position in Concentrix in Q4 2020 and held it in 5 quarters.
- Royce & Associates's Concentrix position peaked at $9.16M in Q4 2020.
- 353 funds tracked by Wall St. Rank held Concentrix as of Q1 2022.
Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.